Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
NY1972
Level Icon Gift Icon

Followers 5
Posts 1,082
Boards Moderated 0
Alias Born 10/03/2015

NY1972
Level Icon Gift Icon

Message
NY1972
Level Icon Gift Icon

Message

Latest Posts

Posts by NY1972 Board Date/Time
recent technical advances using culture conditions with IL-7/IL-15 and Lyell Immunopharma Inc 07/26/2022 10:39:15 PM
Thanks for the link. Lyell Immunopharma Inc 07/24/2022 11:06:21 PM
Which will perform better ? BE with 7,8 Lyell Immunopharma Inc 07/14/2022 11:01:19 PM
Do you need Epigenetic Reprogramming if pts can Lyell Immunopharma Inc 07/11/2022 11:27:17 AM
I am glad you found something scary. 0.49/100K Biotech Values 07/06/2022 03:57:35 PM
You are calling all the PhDs at NYC Biotech Values 07/06/2022 02:11:56 PM
0.5/100K unvaccinated died of covid in NYC. What Biotech Values 07/06/2022 12:50:03 PM
Every American should celebrate on these news. Mother Biotech Values 07/06/2022 12:17:03 PM
Did you see see any study that looked Biotech Values 07/06/2022 11:57:47 AM
Base editing reminds me of vaccine boosters. It DTIL 07/05/2022 08:58:24 PM
120 mil cash + 67 mil deferred revenue Savvy Trades and Investments 06/12/2022 12:38:04 PM
From 10K: DTIL 06/08/2022 11:32:20 PM
The most popular first salvage regimen for relapse DTIL 06/07/2022 09:37:42 AM
Too bad GNCA NPT with CAR knock in Crispr Therapeutics AG 06/07/2022 08:51:45 AM
500 clones from different editing sequences? What gets Crispr Therapeutics AG 06/06/2022 06:05:18 PM
Targeting PARP11 to avert immunosuppression and improve CAR DTIL 06/06/2022 10:10:57 AM
Response MCL AUTO limited by: DTIL 06/04/2022 11:40:40 PM
phase II trial of the autologous anti-CD19 chimeric DTIL 06/04/2022 11:03:54 PM
That is a lot of man made mutations. Crispr Therapeutics AG 06/04/2022 10:39:47 PM
How many gene edit/inserts will be required in Crispr Therapeutics AG 06/04/2022 10:29:41 AM
“The CAR T relapse setting is a rapidly DTIL 06/04/2022 10:15:03 AM
These pharma execs didn't want to talk about DTIL 06/03/2022 10:20:43 PM
Efficient reprogramming of T cells with a CAR DTIL 06/03/2022 12:08:12 PM
NEA just ran GNCA to the ground. Adaptimunne Therapeutics 05/24/2022 10:33:21 AM
Fraud!! Genocea Biosciences Inc. 05/24/2022 10:06:17 AM
Donor T cells and donor genes to treat cancers? DTIL 05/22/2022 09:19:49 PM
Knocking out genes that express IL-1R1, .... in DTIL 05/18/2022 09:35:32 PM
No mention of the primary tumor or antigen Fate Therapeutics Inc. 05/16/2022 11:07:23 PM
How about inserting MMR gene into MSI cancers DTIL 05/16/2022 06:04:53 PM
ATLAS worked. Planet failed. Genocea Biosciences Inc. 05/16/2022 05:20:00 PM
If DTIL can unsteath cancer cells before treating DTIL 05/16/2022 10:51:26 AM
ADXS called that HOT. It turned out to DTIL 05/16/2022 10:20:42 AM
Is 'personalized allogeneic' oxymoron? DTIL 05/15/2022 08:49:45 PM
Cell therapy will be the backbone of therapies DTIL 05/14/2022 09:26:23 PM
NVS should buy DTIL with their stockpile of peanuts. DTIL 05/12/2022 04:13:13 PM
NVS claimed to deliver 10-50 fold few CART DTIL 05/10/2022 08:13:33 PM
Is NVS picking CD39-CD69- t cells? Which alloc DTIL 05/10/2022 11:36:06 AM
ARCUS is safe relatively speaking. DTIL 05/09/2022 11:28:48 AM
Ticking time bomb? monitoring patients undergoing CRISPR-Cas9-based editing DTIL 05/07/2022 07:08:39 PM
Too many biotechs were fat pigs destined for DTIL 05/06/2022 06:39:51 PM